Feb 19 2024, 07:58
5 Indian pharma stocks with upside potential of up to 32%:
The whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance was the Indian pharma companies, yes they are very different in every sense from MNC pharma. During the PSU rally, these pharma stocks have been consolidating, however, in the last few days, some of them have once again started reacting to positive developments in the individual company indicating that there is money on the sideline that is ready to come into these stocks.
Pharma sector, specifically, Indian pharma companies which first came into limelight in 2005, as they were able to make a mark in the US generic market and then went into see many headwinds post 2015 are the ones which belong to the second category. Even in the case of Indian pharma companies, there is a sort of division, first one which is focussed on the Indian market and second one which is focussed on the US generic market.
A number of companies have gone through restructuring, companies which had kept their focus on the domestic market are close to completing their rejig. A number of them kicked off restructuring plans long back, in some cases as long as three to four years back. A few of those plans are close to bearing fruits and some have even successfully got into the international market with Europe as the first entry point.
In the case of companies which were focussed on US markets, they have learned to live with lower margins than they had anticipated and a few of them have moved into generics which are more complex and have higher margins.
Pharma Sector stocks - Upside potential
Feb 18, 2024
Company Name
JB Chemicals & Pharma
Latest Avg Score
6
Reco
Buy
Analyst Count
14
Upside Potential%
32.9
Inst Stake %
24.4
3M Returns %
10.2
1Y Returns %
68.5
Market Cap Rs Cr
25,628
Company Name
Lupin
Latest Avg Score
10
Reco
Hold
Analyst Count
38
Upside Potential%
20.3
Inst Stake%
36.0
3M Returns %
35.7
1Y Returns %
137.7
Market Cap Rs Cr
73,819
Company Name
Ajanta Pharma
Latest Avg Score
9
Reco
Buy
Analyst Count
13
Upside Potential%
17.1
Inst Stake%
22.1
3M Returns %
11.5
1Y Returns%
79.0
Market Cap Rs Cr
27,096
Company Name
Cipla
Latest Avg Score
10
Reco
Buy
Analyst Count
36
Upside Potential%
15.2
Inst Stake%
37.3
3M Returns%
16.7
1Y Returns%
39.1
Market Cap Rs Cr
116,276
Company Name
Torrent Pharma
Latest Avg Score
7
Reco
Buy
Analyst Count
30
* Upside Potential%
12.9
Inst Stake %
13.7
3M Returns %
29.4
1Y Returns%
74.8
Market Cap Rs Cr
89,372
Calculated from highest price target given by analysts
source: et
Feb 19 2024, 07:58